3862 results for «361»
3862 results
Challenging left main interventions
17 May 2023 – From EuroPCR 2023
Seeking to enhance your proficiency in left main interventions? Explore a compelling series of challenging case studies presented by your colleagues to deepen your understanding and refine your skills.
The 2024 top Japanese abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding Japanese abstract submissions from PCR Tokyo Valves 2024, including a study on the effect of chronic kidney disease in clinical outcomes of Japanese patients treated with MitraClip system, and insight into the deformation of transcatheter heart valves with mitral valve-in-valve.
Tricuspid valve disease: diagnosis and classification
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...
Rapid-fire - Complications in SHD interventions
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...
Challenges in TEER for secondary mitral regurgitation
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.
Shaping the future of structural heart disease intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.
Rapid-fire - LAA closure and plugging
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....
TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
Rapid-fire - TAVI concomitant with CAD
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!
Rapid-fire - Tricuspid valve interventions in various situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!
Rapid-fire - Valve-in-Valve TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, gain valuable insights into valve-in-valve TAVI from a rapid-fire series of scenarios that cover structural valve deterioration after SAPIEN 3 implantation, a successful aortic valve-in-valve with balloon valve fracture and coronary protection, and TAV-in-SAV for an extremely small failed surgical valve.
Selection of the 2024 best abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...
Mastering techniques from basic to complex - TAVI basics
16 Feb 2024 – From PCR Tokyo Valves 2024
This session focuses on the basics of TAVI intervention. Learn more about vascular access and closure, the techniques of valve crossing predilatation and wire pacing, and discover the uses of the Evolut FX System for TAVI!
Rapid-fire - Mitral TEER for complex situations
18 Feb 2024 – From PCR Tokyo Valves 2024
This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!
Managing aortic stenosis in patients with longer life expectancy
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.